The former FDA chief Stephen Hahn is now the CEO of a biotech startup called Harbinger Health. Launched by Flagship Pioneering, Harbinger is developing a blood test to detect early-stage cancers. The ...

Following three years of research and development, Flagship unveils Harbinger Health with $50 million of committed capital The views and opinions expressed herein are the views and opinions of the ...

Harbinger Health has raised $140 million to clinically validate a blood-based cancer screening test ahead of a planned launch in 2025. The test is designed to identify epigenetic changes that signal ...

While many new medtech startups spend their first few years struggling to rack up enough capital and cachet to bring their ideas to fruition, Harbinger Health, which emerged from stealth just this ...

A Cambridge biotech run by the former head of the Food and Drug Administration has raised $140 million to complete the study of a blood test it developed to screen for cancers in people without ...

In a positive sign for its future success, Harbinger Health Inc. closed a $140 million series B fundraising round, bringing total funds raised since its founding in 2020 to $190 million. The new funds ...